# Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients

> **NCT07375693** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Bangladesh Medical University** · enrollment: 70 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** MELATONIN (MELATL07959)

## Key facts

- **NCT ID:** NCT07375693
- **Lead sponsor:** Bangladesh Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-17
- **Primary completion:** 2026-08-23
- **Final completion:** 2026-09-15
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375693, "Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07375693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*